FDA approves Novo-Nordisk's diabetes drug Victoza

January 26, 2010 5:54:24 AM PST
Federal health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the disease.

Load Comments